Radiopharm Theranostics Limited (ASX:RAD – Get Free Report) insider Paul Hopper sold 1,500,000 shares of the company’s stock in a transaction on Thursday, December 5th. The stock was sold at an average price of A$0.03 ($0.02), for a total value of A$43,500.00 ($27,707.01).
Radiopharm Theranostics Stock Performance
About Radiopharm Theranostics
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.
Read More
- Five stocks we like better than Radiopharm Theranostics
- Market Cap Calculator: How to Calculate Market Cap
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Canada Bond Market Holiday: How to Invest and Trade
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Earnings Reports?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Radiopharm Theranostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radiopharm Theranostics and related companies with MarketBeat.com's FREE daily email newsletter.
